CMV Intensive Care Units
NCT02324244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2014-12-24
Summary
Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a broad cohort of consecutive immunocompetent adults admitted to a major heart surgery intensive care unit (MHS-ICU) with the goal of determining the epidemiology, risk factors, and clinical significance of CMV infection.
Conditions
- CMV Infection
Sponsors & Collaborators
-
Emilio Bouza
lead OTHER
Principal Investigators
-
Patricia Muñoz, PhD · Hospital General Universitario Gregorio Marañon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- Spain
Study Locations
More Related Trials
-
Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
NCT04280380 ·Status: UNKNOWN
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada
NCT05576805 ·Status: COMPLETED
-
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 ·Status: COMPLETED
-
Breakthrough CMV Lung Transplant -Multicentre
NCT04439916 ·Status: RECRUITING
-
Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.
NCT03699254 ·Status: COMPLETED ·Phase: PHASE3
-
Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis
NCT04916704 ·Status: ACTIVE_NOT_RECRUITING
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
NCT06494033 ·Status: RECRUITING
-
Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients
NCT01008540 ·Status: COMPLETED ·Phase: NA
-
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
NCT00436384 ·Status: COMPLETED
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada
NCT05571137 ·Status: COMPLETED
-
Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
NCT01833416 ·Status: COMPLETED
-
Cytomegalovirus Spread and Reactivation in Blood Cells
NCT00006314 ·Status: COMPLETED
-
Immune Response to Cytomegalovirus
NCT00034437 ·Status: COMPLETED
-
A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.
NCT02067169 ·Status: COMPLETED
-
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
NCT04690933 ·Status: COMPLETED
-
Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress
NCT01397058 ·Status: UNKNOWN
-
Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus
NCT01325636 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
NCT01753167 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China
NCT05958186 ·Status: COMPLETED
-
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
NCT04706507 ·Status: TERMINATED ·Phase: PHASE3
-
Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation
NCT01326273 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
NCT01473849 ·Status: UNKNOWN
-
Ganciclovir Resistant Cytomegalovirus Infection in SOT Recipients.
NCT05234723 ·Status: UNKNOWN
-
Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
NCT00497796 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001531 ·Status: COMPLETED